Homeopathy Research Institute response disputing or criticizing the retraction rationale for the Frass NSCLC study.
Homeopathy
Homeopathy is a alternative, unapproved, or historically promoted cancer therapy promoted by some clinics, authors, practitioners, or patient communities as an anticancer treatment, immune strategy, detoxification method, or substitute for conventional care. In cancer care, it should be evaluated by evidence level, intended use, safety, interactions, and whether it is being used as conventional treatment, supportive care.
Retraction notice for the Frass NSCLC add-on homeopathy trial.
NCI overview explaining that cancer patients may use CAM to cope with treatment side effects, comfort themselves, or try to treat cancer, and that CAM should be discussed with the care team. Used to frame grounding as supportive rather than curative.
Consumer overview of homeopathy for cancer, noting unproven cancer-treatment claims, possible symptom-management interest, and risks of replacing conventional care.
Updated review discussing proposed anticancer potential of homeopathic medicines and preclinical/theoretical literature.
Expression of concern for the Frass NSCLC add-on homeopathy trial.
Cancer Research UK patient resource stating homeopathy is a complementary therapy with no scientific evidence that it can prevent or treat cancer; includes use patterns, side effects, and research overview.
Systematic review of 18 studies and 2016 cancer patients. Reported heterogeneous results, mostly breast cancer, low methodological quality, and no conclusive evidence or scientifically based mechanism for homeopathy in cancer care.
MSK About Herbs entry summarizing homeopathy, limited and inconclusive evidence, patient/provider communication, and safety concerns.
NCCIH overview stating there is little evidence supporting homeopathy for specific health conditions, noting FDA/FTC regulatory concerns, possible product-quality risks, and advice not to replace proven conventional care.
Systematic review of in vitro and in vivo experimental cancer models using homeopathic high dilutions; concluded research is early and needs independent reproduction.
Randomized placebo-controlled multicenter NSCLC add-on homeopathy study that reported quality-of-life and survival benefits; later corrected, flagged with an expression of concern, and retracted in 2025.
Open-access article by Michael Frass on additive homeopathy in cancer patients.
Retrospective feasibility review of 124 patients receiving homeopathic consultation in an integrative oncology service; reported adherence and perceived benefit, without randomized efficacy testing.
Review discussing why cancer patients use homeopathy, skepticism in academic medicine, supportive-care questions, safety, and research challenges.
Open-access book chapter describing Banerji Protocols for multiple cancer types and supportive/palliative aims; proponent protocol source.
Prospective observational study comparing cancer patients receiving complementary classical homeopathy with conventionally treated cancer patients; frequently cited for quality-of-life outcomes but nonrandomized.
Cochrane review of controlled trials for adverse effects of cancer treatments; preliminary findings for topical calendula and Traumeel S mouthwash, but no convincing evidence for other adverse effects and need for replication.
Best Case Series Program report involving cancer patients treated with Banerji protocols. Useful source trail for claims; not equivalent to randomized evidence.
Systematic review critically evaluating homeopathic remedies as sole or additional therapy in cancer care; highlighted controversy, implausibility concerns, and insufficient evidence.
Pilot randomized placebo-controlled trial of individualized homeopathy for estrogen-withdrawal symptoms in breast cancer survivors; cited in homeopathy adverse-effects review.
Phase III randomized trial comparing Calendula officinalis and trolamine for prevention of acute dermatitis during breast cancer radiotherapy; included in homeopathic adverse-effects reviews.
Small randomized trial of Traumeel S mouthwash for chemotherapy-induced stomatitis in children undergoing stem cell transplantation; cited in Cochrane review.
Public overview of the Banerji Protocols, their disease-based approach, and cancer-related claims and history.
Clinica Dr. Spinedi page describing a Swiss homeopathic clinic specializing in chronic degenerative diseases and oncological patients.
Public proponent page listing Banerji Protocols for many cancer types and excerpting protocol tables; claims require independent evaluation.